Results 221 to 230 of about 60,444 (298)

Clinical use of immunosuppressants [PDF]

, 2005
Fung, JJ, Schonder, KS, Starzl, TE, Weber, RJ   +3 more
core  

Hematologic Safety of Radium‐223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial

Clinical Genitourinary Cancer, 2017
N. Vogelzang, R. Coleman, J. Michalski, S. Nilsson, J. O’Sullivan, C. Parker, A. Widmark, M. Thuresson, Lei Xu, J. Germino, O. Sartor   +10 more
semanticscholar   +1 more source

Intrathecal Pemetrexed Administration and Myelosuppression in Patients with Leptomeningeal Metastases from Lung Adenocarcinoma: A Retrospective Study. [PDF]

Oncol Res
Chen J, Pan L, Liu Y, Fang Y, Li R, Lu Z, Liu A, He Y, Zeng Z.   +8 more
europepmc   +1 more source

Disparities in adverse event perception between patients and healthcare providers in gynaecologic anticancer therapy: results from an observational web-based study in Japan. [PDF]

BMJ Open
Hashimoto H, Soejima A, Nishimura Y, Ike A, Sugawara M, Shimada M, Abe M.   +6 more
europepmc   +1 more source

Application value and safety of trilaciclib in first-line chemotherapy combined with immunotherapy for extensive-stage small cell lung cancer: A real-world study. [PDF]

Oncol Lett
Cui Y, Zhang H, Wang L, Lou X.
europepmc   +1 more source

Efficacy of <i>Yang Yin Sheng Xue</i> formula against canine lymphoma chemotherapy-induced myelosuppression. [PDF]

Front Vet Sci
Pan W, Sun R, Shiau D, Xie H, Dong J, Lin J.   +5 more
europepmc   +1 more source

Concomitant IV vancomycin causing delayed high-dose methotrexate clearance and acute kidney injury. [PDF]

J Antimicrob Chemother
Dao T, Loh Z, Tan B, Shortt J, Gregory G, Rogers BA, Rogers BA, Tey A.   +7 more
europepmc   +1 more source

Meta-analysis of clinical efficacy and safety of decitabine combined with CAG regimen in the treatment of acute myeloid leukemia in the elderly. [PDF]

Leuk Res Rep
He Y, Zhang L, Liu M, Zhang F, Gao H.
europepmc   +1 more source

Efficacy of Poloxamer 188 in Experimental Myelosuppression Model Induced by Carboplatin in CBA Mice. [PDF]

Int J Mol Sci
Kholina AV, Borozdina NA, Palikov VA, Mikhaylov ES, Kravchenko IN, Dalevich RA, Pakhomova IA, Kazakova EN, Timchenko MA, Yegorov AY, Molchanov MV, Ermakov AM, Antonova OY, Kochetkova OY, Pankratova NM, Pankratov AN, Arshintseva EV, Pushkin SY, Dyachenko IA, Murashev AN.   +19 more
europepmc   +1 more source

The risk factors for chemotherapy myelosuppression in breast cancer: a systematic review and meta-analysis. [PDF]

Front Genet
Zhu YY, Li Y, Zeng L, Li N.
europepmc   +1 more source